We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News
Cannabis & Psychedelics News

Massachusetts General Hospital Launches New Center for Psychedelics

Analytical Cannabis spoke to Jerrold F. Rosenbaum, director of the Center for the Neuroscience of Psychedelics, to learn more about its research ambitions.

Read More

Cannabis Concentrates May Not Affect Memory as Much as First Thought, Study Finds

A group of researchers have found that, contrary to their predictions, high potency cannabis concentrates don’t seem to significantly impair the memory of regular cannabis consumers much more than lower potency flower products.

Read More

Single Dose of Psilocybin Can Remodel the Brains of Mice, Study Finds

The new study examined structural changes in the brain that might explain psilocybin’s enduring antidepressant effects.

Read More

Rwanda Legalizes Medical Cannabis

Doctors in Rwanda can now prescribe medical cannabis to patients, following a new ministerial order passed by legislators to recognize the medical value of the plant and legalize its medicinal use.

Read More

Colorado Announces New THC Testing Rules for Hemp Products

Some of the requirements are stricter than the equivalent rules for cannabis products.

Read More

Growth Media Used in Total Yeast and Mold Testing Can Significantly Affect Microbial Diversity, Study Finds

The growth media used in plating-based total yeast and mold count (TYMC) tests can dramatically impact the diversity of microbes that grow, according to a new investigation from scientists at Medicinal Genomics.

Read More

Pennsylvania Expands Medical Cannabis Regulations

The bill also permits cannabis companies to remediate their products by extracting them into a topical form should they be contaminated with yeast or mold.

Read More

New Colorado Law Restricts Concentrate Sales

Coming into effect on January 1, 2022, the bill will limit patients aged 21 and over to 8 grams of concentrates per purchase, down from the previous limit of 40 grams.

Read More

 
Advertisement